Celgene’s revenue rose in the most recent period, driven by sales growth of its key cancer treatment, particularly in the U.S. The pharmaceutical company’s top line beat analysts’ expectations, while its profit was in line with them.

Staff reviewers at the U.S. FDA recommended approval for a Novartis copy of an Amgen cancer treatment, Neupogen, a development that could make generic versions of complex biologic therapies more readily accessible in the U.S.

J.P. Morgan Chase & Co. chief James Dimon this week wrapped up his scheduled cancer treatment after first disclosing his throat cancer diagnosis in July. Here's a look at how Mr. Dimon's summer unfolded.

Kenneth von Roenn isn’t your typical stained-glass artist. For starters, he doesn't even like the words “stained glass.” He opts instead to describe his work as art glass or architectural glass. He designs multicolored glass pieces with “an expressive quality,” he says. His projects tower over and droop down skyscrapers. They frame pedestrian bridges to basketball stadiums. A circular glass...

J.P. Morgan Chase chief James Dimon, returning to the public stage after undergoing cancer treatment, said the bank would double spending on cybersecurity, following a data breach at the bank this summer.

A bankruptcy judge Friday paved the way for Dendreon to auction its flagship, Provenge, to the highest bidder, a day after Valeant Pharmaceuticals set a $296 million floor price for the prostate cancer drug.